Abstract
Introduction
Differential cytokine production (T h 1 versus T h 2) by CD4 ϩ T cells during an immune response plays an important role in determining the biological effects of the response. T h 1 cells are characterized by the dominance of IFN-γ production, while T h 2 cells produce predominantly IL-4 (1) . Whether a T h 1-or T h 2-type response occurs to infectious agents can determine whether that response is protective or not. This is best exemplified in the Leishmania model in which T h 1 response are protective (2) (3) (4) . T h 1 and T h 2 cells also play an important role in the primary immune responses, though this has not been firmly established.
Dendritic cells (DC) are the most potent antigen-presenting cells (APC) in priming naive T cells (12) , and investigators have used DC as APC in T h 1 and T h 2 differentiation assays (9, 13) . DC spend a certain amount time in peripheral tissues such as skin (14) or intestine (15) before they migrate to draining lymph nodes where they present antigen to T cells (16) (17) (18) . Thus, their original microenvironment or cytokine milieu may influence their antigen presentation properties at distal sites and whether they induce naive T cells to differentiate along either a T h 1 or T h 2 pathway. In the present report, using an in vitro priming system with highly enriched DC and naive ovalbumin (OVA)-TCR transgenic T cells, we investigated the effect of cytokine milieu on DC-driven T cell differentiation. Our results demonstrate that DC isolated from splenic adherent cell culture treated with rIL-10 (IL-10-DC) prime naive T cells to secrete IL-4 leading to the development of T h 2 cells, whereas DC from rIL-12, rIL-4 or control treated cultures prime almost exclusively for T h 1 cells. Since IL-10 and IL-12 are often present in the early or innate immune response (19, 20) , DC exposed to these cytokines may determine differential T h cell development.
Methods

Animals
OVA 323-339-specific and I-A d -restricted DO11.10 TCR-αβ transgenic mice on a BALB/c genetic background were a kind gift from Dr Dennis Loh (21) and bred at Children's Hospital, Harvard Medical School, Boston. BALB/c mice, 6-8 weeks old, were purchased from the Jackson Laboratory (Bar Harbor, ME).
Culture medium, antigen, antibodies and recombinant cytokines
Complete DMEM consisted of DMEM (BioWhittaker, Walkersville, MD) supplemented with 10% FCS, 2ϫ10 -5 M 2-mercaptoethanol, 1 mM sodium pyruvate, 100 µg/ml penicillin and streptomycin, 2 mM L-glutamine, 10 mM HEPES buffer and 0.1 mM non-essential amino acids. X VIVO-20 serumfree medium was purchased from BioWhittaker. OVA (grade V) was purchased from Sigma (St Louis, MO). Anti-CD4-phycoerythrin (PE) (YTS 191.1), CD25-PE (PC 61 5.3), CD54-PE (KAT-1), CD44-PE (IM7.8.1), CD62L-PE (Mel-14), F4/80 and isotype control antibodies were purchased from Caltag (San Francisco, CA). PE-conjugated antibodies for CD45RB (16A), CD80 (B7-1, 16-10A1), CD86 (B7-2, GL1), MHC class II (I-A d /I-E d , 2G9) and their isotype controls were from PharMingen (San Diego, CA). Anti-CD40 (3/23) was from Serotec (Oxford, UK). N418, an antibody specific for DC, was purchased from Endogen (Cambridge, MA) and biotinylated with a biotinylation kit (Sigma). Avidin-FITC was from Caltag. Anti-TCR clonotypic mAb KJ126 was a gift of Dr Dennis Loh. ELISA antibodies against IL-2, IL-4, IL-10 and IFN-γ were purchased from PharMingen. Anti-IL-4 neutralizing antibody and isotype control were from Genzyme (Cambridge, MA). Recombinant IL-12 was purchased from R & D Systems (Minneapolis, MN). Antibodies for IL-12 p70 were purchased from PharMingen. Antibodies against B7-1(1G10) and B7-2 (2D10) were kindly provided by Dr V. K. Kuchroo. Anti-CD40L mAb (MR1) and control hamster Ig were the gift of Dr M. H. Sayegh.
Preparation of cytokine-treated DC Spleen cells from BALB/c mice were cultured in 100ϫ15 mm culture dishes for 2 h. The non-adherent cells were rinsed away with warmed medium and the adherent cells were cultured overnight in fresh complete DMEM in the presence or absence of mouse rIL-4, rIL-10 or rIL-12. OVA (1 mg/ml) was added into the cultures 3-4 h before harvesting overnight non-adherent cells. DC were enriched by density separation with 15% Percoll (Sigma). The enriched DC (40-60%) were further purified to 80-95% as judged by staining with DCspecific mAb N418 (22) by removing B220 ϩ cells with the BioMag cell sorting system (PerSeptive Biosystems, Framington, MA).
Preparation of naive T cells from OVA-specific TCR transgenic mice Spleen cells from OVA transgenic mice were passed over a nylon wool column and the eluted cells were further purified by removing cells other than CD4 ϩ T cells with BioMag cell sorting using anti MHC class II, anti-B220, CD8 and F4/80 (anti-macrophage) mAb. The highly enriched T cells (90-95% CD4 ϩ cells) were layered over a 50, 60, 66 and 70% Percoll density gradient and centrifuged at 400 g. High-density cells were recovered from interface between 66 and 70%. These cells were CD25 -, CD44 low , CD45 RB high , Mel 14 (CD62L) high , i.e. a naive T cell phenotype.
Priming naive OVA-TCR transgenic CD4 ϩ T cells with cytokine treated DC Naive T cells (4-5ϫ10 6 /well) were cultured in 24-well plates with 2.5ϫ10 5 various cytokine treated and OVA-pulsed DC for 4-5 days. Alternatively, when 48-well plates were used, 2ϫ10 6 naive T cells were cultured with 1ϫ10 5 cytokine treated and OVA-pulsed DC. The recovered cells from 4-5 day cultures were washed 3 times and rested for another 4-5 days with irradiated splenic APC. Viable cells from resting cultures were obtained by density gradient centrifugation using Isopaque-Ficoll (Sigma). The recovered viable cells were re-stimulated in X VIVO 20 medium (BioWhittaker) with OVA (50 µg/ml) and irradiated splenic cells. Supernatants were harvested at 22 h after re-stimulation and cytokines were measured by ELISA.
Flow cytometry DC were incubated with biotinylated N418 followed by incubation with avidin-FITC, hamster anti-mouse B7-1-PE, rat antimouse B7-2-PE, rat anti-mouse MHC class II-PE or rat anti-CD40-PE. For anti-ICAM-1 staining, DC were incubated with biotinylated hamster anti-mouse splenic DC (N418) and rat anti-mouse ICAM-1 mAb followed by incubation with avidin-FITC and goat anti-rat IgG-PE. Stained cells were analyzed with a FACS Star (Becton Dickinson, Mountain View, CA).
Transwell cultures A dual chamber transwell culture system (Costar, Cambridge, MA), which is 24.5 mm in diameter and consists of two IL10-DC or control (CTRL)-DC (4ϫ10 5 in 100 µl) were placed in the upper wells of transwell system as the sources of soluble factors. CTRL-DC (1ϫ10 5 ) and naive CD4 ϩ T cells (2ϫ10 6 ) in 600 µl were placed in the lower wells. In some lower wells, IL10-DC were also added. After 4 days of culture, cells from lower wells were recovered and rested for another 4 days. Viable cells were recovered and restimulated with OVA and splenic APC. Supernatants were harvested and tested for IL-4 and IFN-γ production.
compartments separated by a semi-permeable polycarbonate membrane, with a pore size of 0.4 µm, was used. The two chambers are 1 mm apart, allowing cells to be co-incubated in close proximity without direct cell-cell contact. To determine whether IL-10-DC released soluble factors which promoted IL-4-secreting T cell differentiation, 4ϫ10 5 IL-10-DC were placed in the upper well and 2ϫ10 6 naive CD4 ϩ T cells plus 1ϫ10 5 control-DC in the lower well. After 4-5 days of incubation, T cells from lower wells were harvested, rested for 5 days and these cells were then re-stimulated with irradiated spleen cells and OVA, and supernatants harvested and tested for cytokine production. Different combinations of cells were used in upper wells and lower wells (see Table 1 ).
Data analysis
ELISA results represent mean values from duplicate cultures. Experimental results presented are representative of two to four individual experiments.
Results
IL-10 isolated from splenic adherent cell culture treated with IL-10 prime naive CD4 ϩ T cells to secrete IL-4 upon restimulation
To examine whether exposure to cytokines can influence the ability of DC to prime T cells for differential cytokine secretion, a culture system was established involving separate preparations of purified DC and T cells (See Fig. 1A ). In this system, DC were purified from adherent spleen cells that had been previously exposed to cytokines overnight (rIL-4, rIL-10 or rIL-12) and then antigen (OVA). In the priming cultures, naive CD4 ϩ T cells purified from OVA-TCR transgenic mice were exposed to the treated DC for 4-5 days. These T cells were then rested for 4-5 days in the presence of fresh irradiated splenic APC without further added antigen after which they were then re-stimulated with fresh splenic APC and OVA for 22 h, and supernatants were tested for IL-2, IL-4, IL-10 and IFN-γ production. As shown in Fig. 1(B) , DC isolated from IL-10 (2 ng/ml)-treated cultures primed naive CD4 ϩ T cells to secrete both T h 1-and T h 2-type cytokines (IL-4, IL-2, IFN-γ and IL-10) upon re-stimulation, whereas IL-4, IL-12 or control-DC primed naive T cells to secrete only T h 1 cytokines (IL-2, and IFN-γ). When these primed T cells were further restimulated in vitro (third stimulation), T h 2-type cytokines were produced by T cells primed by IL-10-DC, whereas T cells primed by IL-12, IL-4 or control DC still produced exclusively T h 1-type cytokines (Fig. 1B) . We then tested the effect of various doses of IL-10 in the preincubation culture. As shown in Fig. 1 (C), T cells primed by DC exposed to 6 ng/ml IL-10 secreted predominantly T h 2-type cytokines such as IL-4 and IL-10 with little IFN-γ or IL-2 upon secondary re-stimulation, whereas this was not observed at lower doses (0.5 ng or 2 ng/ml).
The ability of IL-10-DC to prime IL-4-secreting T cells was not due to the effect of IL-10 on antigen processing
Since we pulsed DC with OVA in the presence of IL-10, it was possible that the effect of IL-10-DC on IL-4 priming was the result of altered antigen processing by IL-10. To test this, OVA was added into the spleen cell culture and incubated for 2 h prior to culture with IL-10 ( Fig. 2) . Non-adherent cells were washed away and adherent cells were cultured with IL-10 for 18 h after which DC were enriched and placed in priming cultures as outlined in Fig. 1A . Thus in this experiment, antigen is already processed before IL-10 is added. If the IL-10 was mediating its effect via antigen processing, DC treated with IL-10 after antigen pulsing would not be able to prime for the IL-4-secreting T cells. However, as shown in Fig. 2 , DC treated with IL-10 after OVA pulsing were equally able to prime for IL-4-secreting cells, indicating that IL-10 was not mediating its effect via antigen processing.
Development of IL-4-secreting T cells induced by IL-10-DC requires production of IL-4 in the priming cultures
In a number of experimental systems, endogenous IL-4 production in priming cultures is essential for the differentiation of IL-4-secreting T cells (9, 13, 23) To determine whether this was the case in our system, we added anti-IL-4 neutralizing antibody to the priming culture. As shown in Fig. 3(A) , the presence of anti-IL-4 neutralizing antibody in the priming culture abrogated the induction of IL-4-secreting T cells upon re-stimulation. Moreover, low levels of IL-4 were detected as early as 48 h in primary cultures stimulated by IL-10-DC but not in those stimulated by IL-12-DC or control-DC (Fig. 3B) . In the experiment shown in Fig. 3(C) , IL-10-DC stimulated naive T cells to secrete low levels of IL-4 in a dose-dependent fashion in the primary culture (Fig. 3C ).
IL-10-pretreated DC secrete significantly less IL-12 p70 in the priming culture IL-10 can inhibit macrophage-dependent stimulation of T h 1 cells by blocking IL-12 production by macrophages (24, 25) . It has also been shown that IL-10 suppresses DC stimulated IFN-γ production by CD4 ϩ T cells (26) . We also noticed in the primary culture that IL-10-DC stimulated much less IFN-γ when compared to IL-12-DC, IL-4-DC or control-DC (Fig. 1B) , enriched from splenic adherent cells which had been cultured in the presence or absence of rIL-10, rIL-4, rIL-12 (2 ng/ml) and pulsed with OVA (1 mg/ml) were cultured with 5ϫ10 6 naive CD4 T cells for 4 days (first stimulation, 1°). These cultures were then harvested, washed 3 times and recultured with irradiated fresh splenic APC without antigen for another 4 days. Viable cells were recovered from the resting cultures by density separation with Isopaque-Ficoll and re-stimulated (second stimulation, 2°) with OVA (50 µg/ml) and irradiated fresh splenic APC. After 7-9 days resting, viable cells were re-stimulated again (third stimulation, 3°) with OVA and irradiated splenic APC. At 22 h after each stimulation, supernatants were harvested and tested for cytokine production. (C) Dose response of IL-10 treated DC in priming IL-4-secreting T cells. DC (2ϫ10 5 ) enriched from splenic adherent cells which had been cultured with different dose of rIL-10 and pulsed with OVA (1 mg/ ml) were cultured with 4ϫ10 6 naive CD4 T cells for 4 days. Cultures were then washed and rested for 5 days. Viable cells were recovered and re-stimulated with antigen and splenic APC. Supernatants were harvested and tested for IL-2, IL-4, IL-10 or IFN-γ production.
suggesting that expression of IL-12 in priming cultures induced by IL-10-DC may be down-regulated. It has been shown that APC including DC secrete functional IL-12 (p70) in the primary cultures and the secretion is mediated by CD40L-expressing CD4 ϩ T cells (27) (28) (29) (30) (31) . To investigate the role of IL-12 in our system, we measured IL-12 p70 production in the priming cultures induced by different cytokine-treated DC. The results showed that primary cultures containing IL-10-DC had significantly less IL-12 p70 production than parallel cultures containing IL-4-DC, IL-12-DC or control-DC (Fig. 4) . The production of IL-12 was dependent upon CD40L since anti-CD40L mAb abrogated IL-12 p70 production (Fig. 4) . Since IL-4 is a critical factor for T h 2 cell development and IL-4-DC secreted slightly higher IL-12 and could not induce T h 2 cell differentiation (see above), it is possible that if IL-12 is neutralized in the IL-4-DC preincubation culture, an effect of IL-4 on T h 2 cell differentiation would be seen. Indeed, when anti-IL-12 neutralizing antibody was added into the adherent cell culture in the presence of IL-4, DC enriched from this culture could prime naive T cells to secrete IL-4 upon re-stimulation (Fig. 5) . Interestingly, even in the absence of IL-4, DC from the culture in which IL-12 neutralizing antibody was added could also prime naive T cells to secrete IL-4, although the level was less than that primed by IL-4-DC (Fig. 5) . Anti-IL-12 slightly increased the IL-4 secretion primed by IL-10-DC. This result demonstrates that down-regulation of IL-12 is important for T h 2 cell development. To further investigate the role of IL-12 in regulating the production of IL-4-secreting T cells primed by IL-10-DC, rIL-12 was added either directly into the priming cultures or the preincubation cultures and IL-4 production upon re-stimulation was measured. As shown in Fig. 6(A) , addition of rIL-12 into the priming cultures completely blocked the IL-4 priming capacity of IL-10-DC. Furthermore, when IL-12 was added to the prein- Fig. 2 . IL-10-DC priming for IL-4-secreting T cells was not due to the effect of IL-10 on antigen processing. Spleen cells were cultured in the presence or absence of OVA (1 mg/ml) for 2 h. After removing non-adherent cells, rIL-10 was added and adherent cells were cultured overnight. Cells which were not pulsed with OVA initially were harvested after overnight culture, washed twice with fresh medium and then pulsed with OVA (1 mg/ml) for 2 h. Some adherent cells were cultured overnight in the absence of rIL-10 and pulsed with OVA (1 mg/ml). DC were enriched by 15% Percoll followed by removing B220 ϩ B cells with BioMag beads (see Methods). Enriched DC were then cultured with naive CD4 ϩ T cells. After resting, viable cells were re-stimulated with OVA and splenic APC, and supernatants tested for IL-4 production. 5 ) enriched from splenic adherent cells which had been exposed to rIL-10 and pulsed with OVA were cultured with 2ϫ10 6 naive CD4 T cells in the presence of different concentrations of anti-IL-4 neutralizing antibody for 4 days. After resting for another 4 days, viable cells were re-stimulated with OVA and splenic APC. Supernatants were tested for IL-4 production. (B) A low level of IL-4 was present in the priming cultures induced by IL-10-DC. DC (2.5ϫ10 5 ) enriched from splenic adherent cells which had been cultured in the presence or absence of rIL-10, rIL-12 and pulsed with OVA were cultured with 5ϫ10 6 naive CD4 ϩ T cells in 1.5 ml complete DMEM in 24-well plates. Supernatants were harvested at 20, 48 and 72 h after culture, and tested for IL-4 production. The detection limit for this experiment is 10 pg/ml. (C) Dose response of IL-4 production induced by IL-10-DC. DC (2ϫ10 5 ) enriched from splenic adherent cells which had been incubated with different dose of rIL-10 and pulsed with OVA were cultured with 4ϫ10 6 in 1.2 ml complete DMEM in 24-well plates. After 48 h, 200 µl supernatants were harvested for IL-4 production (also see Fig. 1C ). The detection limit for this experiment is 10 pg/ml. cubation cultures which contained rIL-10, a reduced capacity of IL-10 DC to prime for IL-4 secretion was observed (Fig. 6B) .
Direct contact between IL-10-DC and naive T cells is required for priming IL-4-secreting T cells
One mechanism for the IL-4 priming capacity of IL-10-DC could be that down-regulation of IL-12 in the preincubation cultures induces DC to produce soluble factor (s) in the priming cultures, which then induce IL-4 secretion by naive T cells. To test this, a transwell system was used, in which 4ϫ10 5 IL-10-DC were placed in the upper well and 1ϫ10 5 control-DC plus 2ϫ10 6 CD4 ϩ T cells were placed in the lower well. After 4 days of culture T cells from the lower well were recovered and rested for 5 days before re-stimulation for the detection of IL-4. If soluble factor(s) were responsible for the IL-4 priming capacity of IL-10 DC, then naive CD4 ϩ T cells primed by control-DC in the lower well with 4ϫ10 5 IL-10-DC in the upper well would secrete IL-4 upon re-stimulation. As shown in Table 1 , naive CD4 ϩ T cells primed by control-DC co-cultured with 4ϫ10 5 IL-10-DC in the upper well did not Anti-B7-2 antibody inhibits the IL-4 priming capacity of IL-10-DC It has been shown that B7-2 is a critical co-stimulatory molecule in the initial production of IL-4 (32) and the T h 2 pathway (33) . To determine the role of B7 molecules on the priming capacity of IL-10-DC, anti-B7-1 or anti-B7-2 antibodies were added to the priming culture. As shown in Fig. 7(A) , anti-B7-2 antibody inhibited the differentiation of IL-4-secreting T cells primed by IL-10-pretreated DC, whereas anti-B7-1 slightly increased it. The effect of anti-B7-2 antibody was not due to non-specific toxic effects in the cell culture since reduced IL-4 production was accompanied by increased IFN-γ production (Fig. 7B) . Although there was a differential effect of anti-B7-2 versus anti-B7-1 on IL-10-DC priming, no difference in the expression of B7-1 or B7-2 by IL-10-DC was found in preparations exposed to as much as 8 ng/ml of IL-10 (data not shown). In addition, no significant differences were found in the levels of expression of CD40, ICAM-1 or MHC class II on IL-10-pretreated or control-DC (data not shown).
Discussion
Although it has been suggested that IL-10 may have a role in the development of T h 2-type cells, there is little evidence that IL-10 induces the differentiation of T h 2 cells (9,34) Our findings demonstrate that DC from IL-10-treated cultures can induce naive T cells to differentiate into IL-4-secreting T cells. Most recently, DeSmedt et al. showed that DC from splenic low density cell culture treated with IL-10 were capable of driving. T h 2-type cell differentiation in vivo (35) . Our findings, using an in vitro priming system, are consistent with their in vivo data. We also investigated the possible mechanisms associated with the effect of IL-10-DC in priming naive CD4 ϩ T cells to secrete IL-4 and demonstrated that the ability of IL-10 DC to prime for IL-4-secreting T cells was closely related to the down-regulation of CD40L-mediated IL-12 p70 production by DC in the primary cultures. Although DC isolated from adherent cell cultures treated with IL-10 prime naive CD4 ϩ T cells to secrete IL-4, our data do not exclude the possibility that IL-10 acts on other splenic adherent cells and that subsequent interaction of DC with these cells (or factors secreted by them) may be crucial for DC subsequent ability to induce T cell IL-4 production. One direct way to address this question would be to treat highly purified DC with IL-10 and then perform the priming assay. However, because purified DC die very rapidly in culture in the absence of granulocyte macrophage colony stimulating factor it is not possible to obtain enough viable DC for such an experiment and the addition of exogenous recombinant granulocyte macrophage colony stimulating factor to enhance the survival of DC would alter the biology of the system.
In most experimental systems used by investigators to study T h cell differentiation, DC (or other APC) and naive T cells were cultured in the presence of cytokines (IL-10, IL-4 or IL-12) plus antigen (8, 9, 34, 36) . Thus the effect of cytokines in these systems could be on either T cells or APC. In the present study, we first cultured splenic adherent cells with IL-10 overnight followed by pulsing with OVA. DC were then prepared from overnight non-adherent cells and cultured with naive T cells in the absence of cytokines and antigen. Thus, the effect of IL-10 observed was on DC and not on T cells or other APC. Bone marrow-derived DC spend a certain amount of time in the periphery, where they acquire and process antigens after which they migrate to the draining lymph nodes and present antigen to T cells (16) (17) (18) . Thus the cytokine milieu in which they acquire antigen may have important implications for the type of effector cells that they induce in the draining lymph nodes (T h 1 or T h 2).
We did not find that DC from IL-4 treated cultures were able to prime for IL-4-secreting T cells. In fact, IL-4 DC primed for T h 1-type cells. It is known that addition of IL-4 to cultures of APC plus T cells drives towards T h 2 differentiation. Our studies differ in that we pretreated DC with IL-4 before adding them to the priming cultures. Others have reported that IL-4 pretreated macrophages produced high levels of IL-12 and tumor necrosis factor-α when stimulated by microbial products (37) , which may in turn induce T h 1 differentiation. Similarly, in our system, DC from IL-4 treated cultures also secreted slightly increased levels of IL-12 p70 in the primary cultures in a CD40 ligand-dependent fashion (Fig. 4) . Thus, IL-10 and IL-4 may have different effects on T h cell differentiation depending on whether only APC or both APC and naive T cells are exposed to these cytokines. Nonetheless, even though IL-4-DC could not induce T h 2-type cell differentiation, the presence of IL-4 in the priming culture was essential for the development of IL-4-secreting cells since anti-IL-4 mAb in the priming culture inhibited the priming effect by IL-10-DC. These results are consistent with the presence of low level expression of IL-4 in the primary cultures. Recently, it has been shown that IL-4-secreting T cell differentiation induced by very low or very high dose is also IL-4 dependent (13) . This suggests that endogenous IL-4 may always be essential for T h 2 differentiation and that it represents a second step in the pathway of induction of T h 2 responses by IL-10-DC.
It was also possible that IL-10-DC could secrete soluble factors which could direct T h 2 development from naive CD4 ϩ T cells. However, transwell experiments demonstrated that soluble factors from IL-10-DC were not responsible for the ability of IL-10-DC to prime for IL-4-secreting T cells. Studies by other investigators also found that the effect of IL-10-treated macrophages on T h 1 cytokine production was not dependent on soluble factors from macrophages (38) . In our system, IL-10 does not appear to act in the antigen processing step since DC which have already processed antigen retained the ability to prime IL-4-secreting T cells. IL-10 has been shown to act on APC function independent of antigen processing since it inhibits the production of IFN-γ by T h 1 cells activated by soluble anti-CD3 or by superantigen staphylococcal enterotoxin B (38) .
B7-1 and B7-2 molecules have been shown to have differential effects on T h cell development, with B7-2 playing an important role in the T h 2 pathway (32,33). IL-10 has been reported to regulate B7 molecule expression on blood DC (39) and Langerhans cells (40) . In their recent report, DeSmedt et al. showed that IL-10 could slightly decrease B7-1 expression on splenic DC but B7-2 expression was not affected (35) . While we detected no significant alteration of B7 expression on DC exposed to IL-10, anti-B7-2 treatment abrogated the ability of IL-10-DC to prime for IL-4-secreting T cells, whereas anti-B7-1 slightly increased it. These results suggest that the induction of IL-4-secreting T cells by IL-10-DC requires cell to cell contact via the B7-2 pathway and is consistent with previous studies on the effect of B7-2 on the T cell development. However, high expression of B7-2 in itself is not sufficient for the priming of IL-4-secreting T cells since IL-12 increased B7-1 and B7-2 expression on DC while inducing exclusively T h 1-type cells (data not shown).
IL-10 can suppress macrophage-induced IFN-γ production by down-regulating IL-12 production of macrophages (25, 31) and it has been shown that DC direct naive T cells to differentiate into T h 1-type cells by secreting IL-12 (41) . DeSmedt et al. showed that IL-10 suppressed IL-12 mRNA expression and IL-12 p40 expression of splenic DC (35) . In agreement to their findings, our results also point to a pivotal role of IL-12 in T h cell development at both stages in our experimental system. Addition of rIL-12 to the priming cultures abrogated IL-10-induced IL-4 T cell differentiation. DC enriched from the preincubation cultures into which anti-IL-12 neutralizing antibody was added could prime for IL-4-secreting T cell development. Furthermore, rIL-12 neutralized the effect of IL-10 in the preincubation culture in a dose-dependent fashion. More importantly, IL-10-DC secreted significantly less IL-12 p70 than IL-4-DC, IL-12-DC or control-DC in the primary cultures. This result is consistent with recent reports that IL-10 can suppress CD40L-mediated IL-12 secretion by DC (30, 42) . We also noticed that IFN-γ production was suppressed in the primary cultures induced by IL-10 DC (Fig. 1B) . This may be due to the reduced production of IL-12 p70 by IL-10-DC. IFN-γ has been shown to be essential for maintaining IL-12 signaling in primary cultures leading to T h 1 cell differentiation (43) . Treatment of priming cultures with IL-4 or anti-IFN-γ leads to the loss of IL-12 receptor β2 subunit expression on T cells leading to T h 2-type cell differentiation (43) . Thus lower IFN-γ production caused by reduced IL-12 p70 production in the primary culture may contribute to the induction of T h 2 cell differentiation by IL-10-DC.
Our results suggest that IL-10 in the early or innate immune response is linked to the subsequent development of T h 2 cells. In this regard, it has been suggested that IL-10 produced in the initial phase of the immune response may contribute to the predominant T h 2 cytokine production in parasite infection such as visceral leishmaniasis (44) . In some skin conditions in which T h 2 cytokines are dominant, such as Tape-stripped skin or poison ivy dermatitis, IL-10 expression could be detected in keratinocytes as early as 6 h (45). Skin contact sensitizing antigen application also induced rapid up-regulation of . UV B radiation can suppress T h 1 responses while enhancing T h 2 responses (46) . This may be due to the production of IL-10 by keratinocytes induced by UV B radiation (47). Low-dose oral feeding of antigen leads preferentially to T h 2 cell development (6) and this has been attributed to the mucosal microenvironment (48) . IL-10 is present in the epithelium and other parts of the intestinal microenvironment (49, 50) , and IL-10 is essential in maintaining intestinal homeostatic status since IL-10-deficient mice develop chronic inflammatory bowel diseases (51) . T h 2-dominant responses in experimental schistosomiasis have been shown to be closely related to the large amount of IL-10 production by B cells in the course of infection (52) . It has been shown that normal B cells are not able to secrete IL-12 (53) and this may be responsible for their ability to selectively drive T h 2 cell development. In support of this, in preliminary results we found that IL-10 pretreated activated but not resting B cells could also prime naive T cells for T h 2 cell development, although the capacity of priming was 10 fold lower than for DC (unpublished).
Recently, IL-10 has been shown to drive the differentiation of T regulatory 1 (T r 1) cells. These cells secrete mainly IL-10 and IFN-γ, some transforming growth factor-β but no IL-4 and are able to prevent experimental colitis (54) . IL-10 can also convert immature DC into tolerogenic APC which then have a reduced capacity to induce T h 1 responses (55). Taken together, our results and those from other investigators demonstrate the importance of IL-10 in immune differentiation and regulation. DC dendritic cell OVA ovalbumin PE phycoerythrin
